Main > > >CLASSIFIER. *

Onco.>Lung Cancer>DIAG.: Genomic Sequen- cing Classifier (GSC).
Built on Company s RNA Whole-Transcrip tome Sequencing and Machine-Learning platform. The test uses novel “Field of Injury” science to identify genomic changes associated with lung cancer in current or former smokers by using a simple brushing of the person s airway,
which is collected during a bronchoscopy
USA Launch Date: 2019. 06.26.
(*) Company; Patent; TradeMark & Web-
Sites Available on Request.
UpDate: 2020. 01.13.




Onco.>Thyroid Cancer>Diagnostics: Genomic Sequencing Classifier (GSC) & Expression Atlas provide physicians with a comprehensive solution for a complex landscape in thyroid cancer diagnosis and individualization of care. The combined offering enables physicians to answer multiple clinical questions for their thyroid patients using a single, minimally invasive Fine Needle Aspiration (FNA) sample.
The GSC Test was developed with RNA whole-transcriptome sequencing and machine learning to identify benign thyroid nodules among those deemed indeterminate by cytopathology so that these patients may avoid unnecessary surgery.
USA Launch Date: 2018. 05.10.
(*) Company; Patents; TradeMark & Web-
Site Available on Request.
UpDate: 2020. 01.13.






>CLASSIFIER. *'s products
This section has no products